In a final release of findings on Monday, the C8 Science Panel revealed
a probable link between C8 exposure and high cholesterol in adults and children
living in the Mid Ohio Valley.
The panel of three epidemiologists did not find a link between C8
exposure and Parkinson’s disease, non-malignant liver disease, non-malignant
kidney disease, or osteoarthritis. Despite the link to high cholesterol, the
panel did not find a probable link involving coronary artery disease or high
blood pressure.
The panel was appointed by the court as part of a settlement agreement in
a class action lawsuit filed by area residents against DuPont over the
contamination of local water supplies with the manufacturing substance C8, also
known as PFOA or perfluorooctanoic acid. The manmade chemical compound has been
used in the production of Teflon and other consumer applications at DuPont
Washington Works near Parkersburg, West Virginia since the 1950s. In 2002, local water consumers discovered
that C8 had made its way into wells and aquifers of Ohio communities including
Belpre, Tuppers Plains, Little Hocking, and Pomeroy. The contamination
was also found in public water supplies in Lubeck and Mason County, West
Virginia.
Last December, the C8 Science Panel linked
C8 exposure to pregnancy-induced hypertension. In April, the panel linked
the manmade substance to kidney and testicular cancer. In July, the panel
linked C8 to thyroid disease and ulcerated colitis. Monday’s finding linking
exposure to high cholesterol completes the C8 Science Panel’s obligation to the
court.
Consequently, a medical panel has been
appointed to decide what monitoring or screening might be appropriate for
members of the class in light of the findings. Also, class members who suffer from diseases
linked to C8 are free to proceed with their own personal injury claims against
DuPont. The class action settlement agreement indicates that DuPont may not
dispute that C8 can cause the specific diseases which the C8 Science Panel has
linked to exposure.
Panelist Dr. Kyle Steenland said high
cholesterol impacts approximately 20 percent of the participants in the C8 Health
Study whose blood serum and medical histories were collected as part of the class
action settlement agreement. By following some of those participants over time,
the Science Panel was able to observe a decrease in cholesterol levels as C8
exposure also diminished.
Steenland said while the panel’s
legal role is over, he believes it is important to continue to follow this
population for health outcomes in the future.
For more details, read my story for Heartland Publications:
http://www.mydailysentinel.com/view/full_story/20650202/article-Reports-link-C8-to-high-cholesterol?
For more details, read my story for Heartland Publications:
http://www.mydailysentinel.com/view/full_story/20650202/article-Reports-link-C8-to-high-cholesterol?
1 comment:
I observed your blog using google and I must say, this is most likely one of the greatest nicely ready articles I have come across in a long time. I've bookmarked your site for more posts.
Post a Comment